Details for Patent: 11,359,203
✉ Email this page to a colleague
Which drugs does patent 11,359,203 protect, and when does it expire?
Patent 11,359,203 protects RIVFLOZA and is included in one NDA.
This patent has eighteen patent family members in eleven countries.
Summary for Patent: 11,359,203
Title: | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
Abstract: | This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents. |
Inventor(s): | Brown Bob D., Dudek Henryk T., Lai Cheng |
Assignee: | Dicerna Pharmaceuticals, Inc. |
Application Number: | US16918239 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,359,203
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-001 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Try a Trial | ||
Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-002 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Try a Trial | ||
Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-003 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,359,203
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015330670 | ⤷ Try a Trial | |||
Australia | 2021286295 | ⤷ Try a Trial | |||
Canada | 2964168 | ⤷ Try a Trial | |||
China | 107257858 | ⤷ Try a Trial | |||
Denmark | 3204497 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |